RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genomic Vision Stock

Genomic Vision Net Income 2024

Genomic Vision Net Income

-6.79 M EUR

Ticker

GV.PA

ISIN

FR0011799907

WKN

A110TM

In 2024, Genomic Vision's profit amounted to -6.79 M EUR, a 35.85% increase from the -5 M EUR profit recorded in the previous year.

The Genomic Vision Net Income history

YEARNET INCOME (undefined EUR)
2022-6,790
2021-4,998
2020-5,177
2019-4,608
2018-6,898
2017-9,071
2016-8,613
2015-4,338
2014-2,156
2013-1,070
2012-1,890
201150

Genomic Vision Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Genomic Vision, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Genomic Vision from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Genomic Vision’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Genomic Vision. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Genomic Vision’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Genomic Vision’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Genomic Vision’s growth potential.

Genomic Vision Revenue, EBIT and net profit per share

DateGenomic Vision RevenueGenomic Vision EBITGenomic Vision Net Income
20221.03 M undefined-6.12 M undefined-6.79 M undefined
2021994,000 undefined-4.9 M undefined-5 M undefined
20201.08 M undefined-5.38 M undefined-5.18 M undefined
20191.77 M undefined-4.65 M undefined-4.61 M undefined
20181.11 M undefined-6.4 M undefined-6.9 M undefined
20172.14 M undefined-8.48 M undefined-9.07 M undefined
20161.57 M undefined-8.66 M undefined-8.61 M undefined
20152.36 M undefined-4.39 M undefined-4.34 M undefined
20143.46 M undefined-2.21 M undefined-2.16 M undefined
20132.89 M undefined-1.1 M undefined-1.07 M undefined
20122.9 M undefined-1.87 M undefined-1.89 M undefined
20113.82 M undefined-970,000 undefined50,000 undefined

Genomic Vision stock margins

The Genomic Vision margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genomic Vision. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genomic Vision.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Genomic Vision's sales revenue. A higher gross margin percentage indicates that the Genomic Vision retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Genomic Vision's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Genomic Vision's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Genomic Vision's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Genomic Vision. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Genomic Vision's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Genomic Vision Margin History

Genomic Vision Gross marginGenomic Vision Profit marginGenomic Vision EBIT marginGenomic Vision Profit margin
2022-165.01 %-596.69 %-661.79 %
2021-122.94 %-492.45 %-502.82 %
2020-108.76 %-496.03 %-477.58 %
2019-100.56 %-262.66 %-260.34 %
2018-235.94 %-575.11 %-619.77 %
201733.02 %-395.89 %-423.68 %
201652 %-550.54 %-547.55 %
201595.51 %-186.06 %-183.81 %
201498.41 %-64.08 %-62.4 %
201334.6 %-38.06 %-37.02 %
201221.72 %-64.48 %-65.17 %
201139.79 %-25.39 %1.31 %

Genomic Vision Aktienanalyse

What does Genomic Vision do?

Genomic Vision is a biotechnology company that was founded in 2004. It is based in Bagneux, France, and develops and markets innovative molecular diagnostic tools and services based on its patented platform technology. The company's business model is based on collaboration with large pharmaceutical and diagnostic companies to help accelerate their product development and improve their clinical outcomes. Genomic Vision specializes in genetic diagnostics and offers a platform for analyzing DNA structures, allowing for the detection and quantification of genetic changes associated with various diseases such as cancer, neurological disorders, and rare diseases. The company also offers customized solutions and services tailored to the specific needs of its customers. In addition, Genomic Vision licenses its technology and patents to pharmaceutical companies and other organizations. The company has already partnered with Hitachi High-Technologies in Japan to market its platform for cancer monitoring and to develop molecular tests for cancer and other diseases. Genomic Vision has also introduced products such as the FiberVision system for visualizing and analyzing DNA fibers and is working on a new diagnostic test for precise diagnosis of autism and other neurological disorders. The company aims to improve the diagnosis of genetic diseases and advance genomic research. With its patented technology and expertise in molecular diagnostics, Genomic Vision is well positioned to drive the development of new and innovative products. Overall, Genomic Vision is an emerging company focused on the development of molecular diagnostic tools and services, and has a solid foundation in DNA visualization and analysis. With its innovative products and services, the company is well positioned to drive the growth of the molecular diagnostics market and establish itself as a key player in the field. Genomic Vision ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Genomic Vision's Profit Margins

The profit margins of Genomic Vision represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Genomic Vision's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Genomic Vision's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Genomic Vision's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Genomic Vision’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Genomic Vision stock

How much profit has Genomic Vision made this year?

Genomic Vision has made -6.79 M EUR this year.

How has the profit developed compared to last year?

The profit has increased by 35.85% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Genomic Vision publish its earnings?

Genomic Vision publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Genomic Vision?

The profits of Genomic Vision are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Genomic Vision?

You can learn more about the earnings of Genomic Vision by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Genomic Vision pay?

Over the past 12 months, Genomic Vision paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genomic Vision is expected to pay a dividend of 0 EUR.

What is the dividend yield of Genomic Vision?

The current dividend yield of Genomic Vision is .

When does Genomic Vision pay dividends?

Genomic Vision pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genomic Vision?

Genomic Vision paid dividends every year for the past 0 years.

What is the dividend of Genomic Vision?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genomic Vision located?

Genomic Vision is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genomic Vision kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genomic Vision from 9/28/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Genomic Vision pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Genomic Vision in the year 2023?

In the year 2023, Genomic Vision distributed 0 EUR as dividends.

In which currency does Genomic Vision pay out the dividend?

The dividends of Genomic Vision are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genomic Vision

Our stock analysis for Genomic Vision Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomic Vision Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.